系统性红斑狼疮的代谢组学:系统综述与荟萃分析
结果显示SLE患者异亮氨酸、亮氨酸、色氨酸降低,甲硫氨酸升高,油酸升高、癸酸降低,并呈现三羧酸循环中间产物减少、酰基肉碱蓄积及氧化脂质特征。
要点
- SLE患者支链氨基酸(异亮氨酸、亮氨酸)与色氨酸较健康对照降低。
- SLE患者甲硫氨酸升高,油酸升高、癸酸降低,提示脂质重塑。
- 三羧酸循环中间产物减少、酰基肉碱蓄积及氧化脂质特征提示线粒体应激与氧化还原失衡。
核心结论
- 代谢组学可识别可重复的SLE代谢特征,涉及氨基酸与脂质代谢改变,提示线粒体能量学受损及一碳流改变。
研究设计与样本
- 采用随机效应荟萃分析,效应量为均值比(RoM),异质性用I²统计量评估。
主要发现
- 异亮氨酸(RoM=0.73,95%CI=0.72-0.74,I²=0%)、亮氨酸(RoM=0.81,95%CI=0.80-0.81,I²=0%)和色氨酸(RoM=0.73,95%CI=0.64-0.84,I²=75%)在SLE患者中显著低于对照。
- 甲硫氨酸在SLE患者中显著高于对照(RoM=1.54,95%CI=1.26-1.88,I²=88%)。
- 油酸升高(RoM=1.42,95%CI=1.19-1.69,I²=0%),癸酸降低(RoM=0.80,95%CI=0.67-0.95,I²=31%)。
- 定性合成显示三羧酸循环中间产物一致减少、酰基肉碱蓄积及氧化脂质特征(如9-羟基十八碳二烯酸、白三烯B4)。
关键数值与推荐
- 异亮氨酸RoM=0.73(95%CI=0.72-0.74,I²=0%),亮氨酸RoM=0.81(95%CI=0.80-0.81,I²=0%),色氨酸RoM=0.73(95%CI=0.64-0.84,I²=75%)。
- 甲硫氨酸RoM=1.54(95%CI=1.26-1.88,I²=88%),油酸RoM=1.42(95%CI=1.19-1.69,I²=0%),癸酸RoM=0.80(95%CI=0.67-0.95,I²=31%)。
临床怎么用
- 上述代谢物差异可作为SLE候选生物标志物方向,但尚不能直接用于临床诊断或疾病活动度评估。
- 支链氨基酸降低、甲硫氨酸升高及脂质重塑模式或有助于理解SLE的代谢病理机制。
局限性
- 纳入研究为观察性研究,代谢组学平台与样本处理可能影响结果可比性。
- 部分代谢物合并分析异质性较高(甲硫氨酸I²=88%,色氨酸I²=75%)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Systemic lupus erythematosus (SLE) still lacks highly specific biomarkers; high-throughput metabolomics offers a route to elucidate disease-defining metabolic perturbations. OBJECTIVE: This systematic review aims to identify common metabolite changes related to SLE. METHODS: PubMed, Web of Science, Scopus, and the Cochrane Library were searched through November 2024 for human observational studies comparing the metabolomic profiles of adult SLE patients with those of healthy controls. Random-effects meta-analyses used the ratio of means (RoM); heterogeneity was assessed using the I² statistic. RESULTS: Forty-six studies comprising 2,238 SLE patients and 1,761 healthy controls (total n = 3,999) were included. Ten metabolites, each reported in ≥2 of the five eligible studies, were quantitatively synthesized. Compared with controls, isoleucine (RoM = 0.73, 95 % CI = 0.72-0.74, I² = 0 %), leucine (RoM = 0.81, 95 % CI = 0.80-0.81, I² = 0 %), and tryptophan (RoM = 0.73, 95 % CI = 0.64-0.84, I² = 75 %) were significantly lower in SLE, whereas methionine was significantly higher (RoM = 1.54, 95 % CI = 1.26-1.88, I² = 88 %). Lipid remodeling included elevated oleic acid (RoM = 1.42, 95 % CI = 1.19-1.69, I² = 0 %) and reduced capric acid (RoM = 0.80, 95 % CI = 0.67-0.95, I² = 31 %). Qualitative synthesis revealed consistent reduction of tricarboxylic acid intermediates, accumulation of acylcarnitines, and an oxidized-lipid signature (e.g., 9-hydroxyoctadecadienoic acid, leukotriene B4), implying mitochondrial stress and redox imbalance. CONCLUSIONS: Metabolomic profiling identifies a reproducible SLE signature: relative to controls, branched-chain (isoleucine, leucine) and aromatic (tryptophan) amino acids are lower, methionine is higher, and lipid profiles show higher oleic and lower capric acids, patterns consistent with impaired mitochondrial energetics and altered one-carbon flux.
引用
- Barrera-Hernández S, Mendoza-Pinto C, Munguía-Realpozo P, et al. Metabolomics in systemic lupus erythematosus: A systematic review and meta-analysis. Semin Arthritis Rheum. 2025. PMID: 41435614. doi:10.1016/j.semarthrit.2025.152893
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。